%0 Generic
%A Karachaliou, N.
%A Cardona Zorrilla, A.
%A Rodriguez-Abreu, D.
%A Cobo Dols, M.
%A Reguart Aransay, N.
%A Viteri, S.
%A Codony-Servat, J.
%A Molina-Vila, M. A.
%A D'Hondt, E.
%A Rosell, R.
%T Afatinib plus EGF pathway targeting immunization (EGF-PTI) as first line therapy for EGFR mutant NSCLC: The EPICAL study
%D 2018
%@ 1556-0864
%U https://hdl.handle.net/10668/24379
%~